BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 21706233)

  • 1. Promoter methylation status of hMLH1, hMSH2, and MGMT genes in colorectal cancer associated with adenoma-carcinoma sequence.
    Lee KH; Lee JS; Nam JH; Choi C; Lee MC; Park CS; Juhng SW; Lee JH
    Langenbecks Arch Surg; 2011 Oct; 396(7):1017-26. PubMed ID: 21706233
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Promoter methylation status of MGMT, hMSH2, and hMLH1 and its relationship to corresponding protein expression and TP53 mutations in human esophageal squamous cell carcinoma.
    Su Y; Yin L; Liu R; Sheng J; Yang M; Wang Y; Pan E; Guo W; Pu Y; Zhang J; Liang G
    Med Oncol; 2014 Feb; 31(2):784. PubMed ID: 24366688
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aberrant methylation of different DNA repair genes demonstrates distinct prognostic value for esophageal cancer.
    Ling ZQ; Li P; Ge MH; Hu FJ; Fang XH; Dong ZM; Mao WM
    Dig Dis Sci; 2011 Oct; 56(10):2992-3004. PubMed ID: 21674174
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Promoter methylation status of hMLH1, MGMT, and CDKN2A/p16 in colorectal adenomas.
    Psofaki V; Kalogera C; Tzambouras N; Stephanou D; Tsianos E; Seferiadis K; Kolios G
    World J Gastroenterol; 2010 Jul; 16(28):3553-60. PubMed ID: 20653064
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protein expression and methylation of DNA repair genes hMLH1, hMSH2, MGMT and BRCA1 and their correlation with clinicopathological parameters and prognosis in basal-like breast cancer.
    Alkam Y; Mitomi H; Nakai K; Himuro T; Saito T; Takahashi M; Arakawa A; Yao T; Saito M
    Histopathology; 2013 Nov; 63(5):713-25. PubMed ID: 24004112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Normal colorectal mucosa exhibits sex- and segment-specific susceptibility to DNA methylation at the hMLH1 and MGMT promoters.
    Menigatti M; Truninger K; Gebbers JO; Marbet U; Marra G; Schär P
    Oncogene; 2009 Feb; 28(6):899-909. PubMed ID: 19060925
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aberrant DNA methylation of P16, MGMT, hMLH1 and hMSH2 genes in combination with the MTHFR C677T genetic polymorphism in gastric cancer.
    Xiong HL; Liu XQ; Sun AH; He Y; Li J; Xia Y
    Asian Pac J Cancer Prev; 2013; 14(5):3139-42. PubMed ID: 23803092
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Promoter methylation status of the MGMT, hMLH1, and CDKN2A/p16 genes in non-neoplastic mucosa of patients with and without colorectal adenomas.
    Ye C; Shrubsole MJ; Cai Q; Ness R; Grady WM; Smalley W; Cai H; Washington K; Zheng W
    Oncol Rep; 2006 Aug; 16(2):429-35. PubMed ID: 16820927
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular features of colorectal hyperplastic polyps and sessile serrated adenoma/polyps from Korea.
    Kim KM; Lee EJ; Ha S; Kang SY; Jang KT; Park CK; Kim JY; Kim YH; Chang DK; Odze RD
    Am J Surg Pathol; 2011 Sep; 35(9):1274-86. PubMed ID: 21836485
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epigenetic-genetic interactions in the APC/WNT, RAS/RAF, and P53 pathways in colorectal carcinoma.
    Suehiro Y; Wong CW; Chirieac LR; Kondo Y; Shen L; Webb CR; Chan YW; Chan AS; Chan TL; Wu TT; Rashid A; Hamanaka Y; Hinoda Y; Shannon RL; Wang X; Morris J; Issa JP; Yuen ST; Leung SY; Hamilton SR
    Clin Cancer Res; 2008 May; 14(9):2560-9. PubMed ID: 18451217
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Promoter methylation and immunohistochemical expression of hMLH1 and hMSH2 in sporadic colorectal cancer: a study from India.
    Malhotra P; Anwar M; Kochhar R; Ahmad S; Vaiphei K; Mahmood S
    Tumour Biol; 2014 Apr; 35(4):3679-87. PubMed ID: 24317816
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Promoter methylation of MGMT, MLH1 and RASSF1A tumor suppressor genes in head and neck squamous cell carcinoma: pharmacological genome demethylation reduces proliferation of head and neck squamous carcinoma cells.
    Koutsimpelas D; Pongsapich W; Heinrich U; Mann S; Mann WJ; Brieger J
    Oncol Rep; 2012 Apr; 27(4):1135-41. PubMed ID: 22246327
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression and promoter methylation status of hMLH1, MGMT, APC, and CDH1 genes in patients with colon adenocarcinoma.
    Michailidi C; Theocharis S; Tsourouflis G; Pletsa V; Kouraklis G; Patsouris E; Papavassiliou AG; Troungos C
    Exp Biol Med (Maywood); 2015 Dec; 240(12):1599-605. PubMed ID: 25908636
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The high frequency of de novo promoter methylation in synchronous primary endometrial and ovarian carcinomas.
    Furlan D; Carnevali I; Marcomini B; Cerutti R; Dainese E; Capella C; Riva C
    Clin Cancer Res; 2006 Jun; 12(11 Pt 1):3329-36. PubMed ID: 16740754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Promoter methylation of the hMLH1 gene and protein expression of human mutL homolog 1 and human mutS homolog 2 in resected esophageal squamous cell carcinoma.
    Tzao C; Hsu HS; Sun GH; Lai HL; Wang YC; Tung HJ; Yu CP; Cheng YL; Lee SC
    J Thorac Cardiovasc Surg; 2005 Nov; 130(5):1371. PubMed ID: 16256791
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic significance of hMLH1/hMSH2 gene mutations and hMLH1 promoter methylation in sporadic colorectal cancer.
    Wang Y; Li D; Li X; Teng C; Zhu L; Cui B; Zhao Y; Hu F
    Med Oncol; 2014 Jul; 31(7):39. PubMed ID: 24990217
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical implications of mismatched repair gene promoter methylation in pancreatic cancer.
    Li M; Zhao ZW
    Med Oncol; 2012 Jun; 29(2):970-6. PubMed ID: 21660619
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Support for hMLH1 and MGMT silencing as a mechanism of tumorigenesis in the hyperplastic-adenoma-carcinoma (serrated) carcinogenic pathway in the colon.
    Oh K; Redston M; Odze RD
    Hum Pathol; 2005 Jan; 36(1):101-11. PubMed ID: 15712188
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Promoter hypermethylation of mismatch repair genes, hMLH1 and hMSH2 in oral squamous cell carcinoma.
    Czerninski R; Krichevsky S; Ashhab Y; Gazit D; Patel V; Ben-Yehuda D
    Oral Dis; 2009 Apr; 15(3):206-13. PubMed ID: 19207881
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MMR-proficient and MMR-deficient colorectal cancer cells: 5-Fluorouracil treatment response and correlation to CD133 and MGMT expression.
    Oliver JA; Ortiz R; Jimenez-Luna C; Cabeza L; Perazzoli G; Caba O; Mesas C; Melguizo C; Prados J
    J Biosci; 2020; 45():. PubMed ID: 33097678
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.